N

Nucleix Ltd.

62 employees

Nucleix develops, manufactures, and markets non-invasive molecular cancer diagnostic tests.

Basic info

Industry

biotechnology research

Sectors

Medical Device
Biotechnology
Personal Health
Lung Cancer
Cancer Diagnostics
Non muscle invasive bladder
Bladder Cancer
Surveilance
Follow up
Health Care
Manufacturing
NGS
Detection
Urinary biomarkers
Methylation Test
Information Technology

Date founded

2008

Funding rounds raised

Total raised

$55M

from 12 investors over 12 rounds

N

Nucleix Ltd. raised $22M on January 5, 2022

Investors: RA Capital Management, L.P., Sands Capital Management and OrbiMed Advisors

N

Nucleix Ltd. raised $55M on April 7, 2021

Investors: Lilly Asia Ventures, LYFE Capital, DSC Investment, OrbiMed Advisors, MILFAM LLC and RA Capital Management, L.P.

N

Nucleix Ltd. raised $3M on May 24, 2016

Investors: OrbiMed Advisors and Aurum Ventures MKI Ltd.

N

Nucleix Ltd. raised $59K on January 10, 2015

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ